528 related articles for article (PubMed ID: 25457227)
21. The Massachusetts General Hospital studies of gender influences on attention-deficit/hyperactivity disorder in youth and relatives.
Biederman J; Faraone SV
Psychiatr Clin North Am; 2004 Jun; 27(2):225-32. PubMed ID: 15063995
[TBL] [Abstract][Full Text] [Related]
22. Methylphenidate doses in Attention Deficit/Hyperactivity Disorder and comorbid substance use disorders.
Skoglund C; Brandt L; D'Onofrio B; Larsson H; Franck J
Eur Neuropsychopharmacol; 2017 Nov; 27(11):1144-1152. PubMed ID: 28935267
[TBL] [Abstract][Full Text] [Related]
23. Specificity in Etiology of Subtypes of Bipolar Disorder: Evidence From a Swedish Population-Based Family Study.
Song J; Kuja-Halkola R; Sjölander A; Bergen SE; Larsson H; Landén M; Lichtenstein P
Biol Psychiatry; 2018 Dec; 84(11):810-816. PubMed ID: 29331354
[TBL] [Abstract][Full Text] [Related]
24. Attention-deficit/hyperactivity disorder and comorbid disruptive behavior disorders: evidence of pleiotropy and new susceptibility loci.
Jain M; Palacio LG; Castellanos FX; Palacio JD; Pineda D; Restrepo MI; Muñoz JF; Lopera F; Wallis D; Berg K; Bailey-Wilson JE; Arcos-Burgos M; Muenke M
Biol Psychiatry; 2007 Jun; 61(12):1329-39. PubMed ID: 16950213
[TBL] [Abstract][Full Text] [Related]
25. Is attention-deficit/hyperactivity disorder associated with illicit substance use disorders in male adolescents? A community-based case-control study.
Szobot CM; Rohde LA; Bukstein O; Molina BS; Martins C; Ruaro P; Pechansky F
Addiction; 2007 Jul; 102(7):1122-30. PubMed ID: 17567400
[TBL] [Abstract][Full Text] [Related]
26. Familial risk analysis of the association between attention-deficit/hyperactivity disorder and psychoactive substance use disorders.
Milberger S; Faraone SV; Biederman J; Chu MP; Wilens T
Arch Pediatr Adolesc Med; 1998 Oct; 152(10):945-51. PubMed ID: 9790603
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of adult attention deficit hyperactivity disorder in the relatives of patients with bipolar disorder.
Turkyilmaz E; Yavuz BG; Karamustafalioglu O; Ozer OA; Bakim B
Int J Psychiatry Clin Pract; 2012 Sep; 16(3):223-8. PubMed ID: 22486581
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of adults with attention deficit hyperactivity disorder plus substance use disorder: the role of psychiatric comorbidity.
Wilens TE; Kwon A; Tanguay S; Chase R; Moore H; Faraone SV; Biederman J
Am J Addict; 2005; 14(4):319-27. PubMed ID: 16188712
[TBL] [Abstract][Full Text] [Related]
29. Does exposure to parental substance use disorders increase offspring risk for a substance use disorder? A longitudinal follow-up study into young adulthood.
Yule AM; Wilens TE; Martelon M; Rosenthal L; Biederman J
Drug Alcohol Depend; 2018 May; 186():154-158. PubMed ID: 29573650
[TBL] [Abstract][Full Text] [Related]
30. Substance use disorder and ADHD: is ADHD a particularly "specific" risk factor?
Kousha M; Shahrivar Z; Alaghband-Rad J
J Atten Disord; 2012 May; 16(4):325-32. PubMed ID: 22127397
[TBL] [Abstract][Full Text] [Related]
31. Attention deficit hyperactivity disorder and substance use disorders.
Szobot CM; Bukstein O
Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
[TBL] [Abstract][Full Text] [Related]
32. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study.
Dalsgaard S; Østergaard SD; Leckman JF; Mortensen PB; Pedersen MG
Lancet; 2015 May; 385(9983):2190-6. PubMed ID: 25726514
[TBL] [Abstract][Full Text] [Related]
33. Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study.
Chen Q; Hartman CA; Haavik J; Harro J; Klungsøyr K; Hegvik TA; Wanders R; Ottosen C; Dalsgaard S; Faraone SV; Larsson H
PLoS One; 2018; 13(9):e0204516. PubMed ID: 30256837
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.
van Emmerik-van Oortmerssen K; van de Glind G; van den Brink W; Smit F; Crunelle CL; Swets M; Schoevers RA
Drug Alcohol Depend; 2012 Apr; 122(1-2):11-9. PubMed ID: 22209385
[TBL] [Abstract][Full Text] [Related]
35. Shared familial risk factors between attention-deficit/hyperactivity disorder and overweight/obesity - a population-based familial coaggregation study in Sweden.
Chen Q; Kuja-Halkola R; Sjölander A; Serlachius E; Cortese S; Faraone SV; Almqvist C; Larsson H
J Child Psychol Psychiatry; 2017 Jun; 58(6):711-718. PubMed ID: 28121008
[TBL] [Abstract][Full Text] [Related]
36. Attention deficit hyperactivity and oppositional defiant disorder symptoms in adolescence and risk of substance use disorders-A general population-based birth cohort study.
Mustonen A; Rodriguez A; Scott JG; Vuori M; Hurtig T; Halt AH; Miettunen J; Alakokkare AE; Niemelä S
Acta Psychiatr Scand; 2023 Sep; 148(3):277-287. PubMed ID: 37431766
[TBL] [Abstract][Full Text] [Related]
37. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
Upadhyaya HP
J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
[TBL] [Abstract][Full Text] [Related]
38. Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth.
Wilens TE; Biederman J
J Psychopharmacol; 2006 Jul; 20(4):580-8. PubMed ID: 16174669
[TBL] [Abstract][Full Text] [Related]
39. Emotional lability in children and adolescents with attention deficit/hyperactivity disorder (ADHD): clinical correlates and familial prevalence.
Sobanski E; Banaschewski T; Asherson P; Buitelaar J; Chen W; Franke B; Holtmann M; Krumm B; Sergeant J; Sonuga-Barke E; Stringaris A; Taylor E; Anney R; Ebstein RP; Gill M; Miranda A; Mulas F; Oades RD; Roeyers H; Rothenberger A; Steinhausen HC; Faraone SV
J Child Psychol Psychiatry; 2010 Aug; 51(8):915-23. PubMed ID: 20132417
[TBL] [Abstract][Full Text] [Related]
40. The co-occurrence of autism spectrum disorder and attention-deficit/hyperactivity disorder symptoms in parents of children with ASD or ASD with ADHD.
van Steijn DJ; Richards JS; Oerlemans AM; de Ruiter SW; van Aken MA; Franke B; Buitelaar JK; Rommelse NN
J Child Psychol Psychiatry; 2012 Sep; 53(9):954-63. PubMed ID: 22537103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
